申请人:A. Nattermann & Cie GmbH
公开号:US04565659A1
公开(公告)日:1986-01-21
The invention concerns new substituted aminoalkanol phospholipids of the general Formula I ##STR1## and methods for the treatment of humans suffering from high blood-pressure (hypertension), from inflammatory illnesses, from tumors and/or atherosclerosis by administering medicaments containing such a compound as well as methods for plant protections.
这项发明涉及一种新的取代氨基烷醇磷脂类化合物,其一般化学式如下所示,并提供了一种治疗高血压、炎症性疾病、肿瘤和/或动脉粥样硬化的方法,该方法是通过给患者使用含有这种化合物的药物,并提供了一种植物保护的方法。